Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COMETRIQ safely and effectively. See full prescribing information for COMETRIQ. COMETRIQ® (cabozantinib) capsules, for oral useInitial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
COMETRIQ is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
- generic_name
- cabozantinib
- product_names
- cabozantinib
- ndc
- 42388-011, 42388-012, 42388-013, 42388-011-14, 42388-012-14, 42388-013-14
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en